INVESTIGATION OF EFFECTS OF VITAMIN D AND VITAMIN D METABOLIZING CYP450 ISOZYMES ON MULTIPLE SCLEROSIS PATHOPHYSIOLOGY IN ANIMAL MODEL BY MOLECULAR APPROACHES

Download

10415157.pdf

Date

2021-8

Author

Evin, Emre

Metadata

Show full item record

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Item Usage Stats

295
views

204
downloads

Multiple sclerosis (MS) is a complicated, recurrent, and often progressive inflammatory demyelinating autoimmune disease of the central nervous system, yet etiopathogenesis remains unsolved. MS frequency increases with increasing latitude, leading to a hypothesis that MS is inversely correlated with the duration and intensity of sunlight and vitamin D concentrations. In this study, the relationships between vitamin D supplementation, MS, VDR, and vitamin D metabolizing CYP enzymes, including CYP2R1, CYP27A1, CYP27B1, and CYP24A1 at mRNA and protein expression levels, were investigated by qRT-PCR and Western blotting techniques in female C57BL/6 mouse autoimmune encephalomyelitis (EAE) model. Both mRNA and protein expressions of Gr 1 were set to 1.00 fold, and expressions of the other groups were calculated relatively to Gr 1. At first, mice were divided into four groups; Gr 1 (control), Gr 2 (vitamin D supplemented control), Gr 3 (EAE), and Gr 4 (vitamin D supplemented EAE). According to the results of this study, vitamin D was not a preventive but a therapeutic agent since significantly higher numbers of mice were recovered in the Gr 4 (8 mice out of 12) than the Gr 3 (2 mice out of 12) (p=0.013<0.05). There was no statistically significant difference in CYP27A1 mRNA and protein expression among the groups. CYP2R1 mRNA expression was significantly low in Gr 4 (0.50 fold; p<0.05). However, CYP2R1 protein expression was not significantly different between the groups. CYP27B1 mRNA and protein expression were significantly high in Gr 2 and Gr 4 compared to Gr 3. CYP24A1 protein expression was higher in Gr 4 (1.70±0.46; p<0.05), which was positively correlated with the clinical score of the EAE. Although VDR mRNA expression increases with the EAE immunization, it was reverted in protein expression levels probably because of the post-transcriptional regulations by miRNAs. In conclusion, vitamin D supplementation and CYP24A1 inhibitor therapy may help to reduce the severity of MS symptoms.

Subject Keywords

Vitamin D, Experimental autoimmune encephalomyelitis, VDR, Vitamin D metabolizing CYPs,, Multiple sclerosis

URI

https://hdl.handle.net/11511/91679

Collections

Graduate School of Natural and Applied Sciences, Thesis

Suggestions

OpenMETU
Core

Analyzing the expression patterns of vitamin D metabolizing CYP27B1 and CYP24A1 in brain tissue of vitamin D treated mice with Multiple Sclerosis (MS) Özdoğan, Dilara; Adalı, Orhan; Evin, Emre; Department of Molecular Biology and Genetics (2022-8) The etiopathogenesis of Multiple Sclerosis (MS), an inflammatory demyelinating autoimmune disease of the central nervous system, is still unknown. MS is a complex, recurring, and frequently progressing condition. There is a hypothesis that MS is adversely associated with the length and intensity of sunlight exposure and vitamin D concentrations since MS frequency rises with increasing latitude. A female C57BL/6 mouse model for autoimmune encephalomyelitis (EAE) was used in this investigation to examine the ...
Investigation of Glutathione S-Transferase (GST) expression and activity in mouse with Multiple Sclerosis (MS) Arçak, Deniz; Adalı, Orhan; Evin, Emre; Department of Biology (2022-5-11) Multiple Sclerosis (MS) of unknown etiopathogenesis is a chronic demyelinating disease of the central nervous system. It mainly destroys myelin in the brain and spinal cord. Non-traumatic injuries have been observed in this disease for young adults. Various factors affect MS, but oxidative stress is one of the most important causes of demyelination. Glutathione S- Transferases (GSTs) can be described as a versatile enzyme family of eukaryotic and prokaryotic phase II metabolic isoenzymes. They have enzymati...
INVESTIGATION OF INFLAMMATION ASSOCIATED CYP2E1 AND CYP1A1 EXPRESSION IN THE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS MOUSE MODEL OF MULTIPLE SCLEROSIS Solak, Damla; Adalı, Orhan; Department of Molecular Biology and Genetics (2023-1-27) Multiple sclerosis (MS) is an autoimmune neurodegenerative disease which affects brain and spinal cord. Myelin which wraps around the axon and its progenitor cells, oligodendrocytes, are destroyed in this disease. This results in the loss of signal transmission which leads to axonal, and eventually neuronal loss. There are various symptoms of the disease such as unstable feelings, fatigue, visual disability, muscle spasms, and walking difficulties. The etiology of the disease is still in its infancy; howeve...
Generation and Characterization of Induced Pluripotent Stem Cell Lines From Multiple Sclerosis Patients and Healthy Individuals Begentaş, Onur Can; Kiriş, Erkan; Department of Molecular Biology and Genetics (2021-9-8) Multiple Sclerosis (MS) is an autoimmune disease characterized by inflammation, demyelination, and axonal damage resulting in neurodegeneration in the central nervous system (CNS). Relapsing-remitting MS (RRMS) is the most common form of the disease known to affect more than 2 million individuals globally, and the prevalence of the disease is increasing worldwide. As a chronic condition without a cure, RRMS manifests in a relapsing-remitting form with sporadic attacks suddenly appearing, causing neurologica...
ASSOCIATION OF THE VITAMIN D METABOLIZING CYP24A1, CYP27A1, CYP27B1 AND VITAMIN D RECEPTOR GENETIC POLYMORPHISMS WITH MULTIPLE SCLEROSIS RISK IN TURKISH POPULATION Bulut, Giray; Adalı, Orhan; Demirkaya, Şeref; Department of Biochemistry (2023-1-25) Multiple Sclerosis (MS) is the most common nontraumatic cause of young disability. There are many studies indicating the relationship between MS and vitamin D. Activation of vitamin D requires a series of hydroxylations that are conducted by cytochrome P450 enzymes (CYPs). Vitamin D shows its effects by binding to vitamin D receptor (VDR). In the present study, vitamin D metabolism related mitochondrial CYPs (CYP27A1, CYP27B1 and CYP24A1) and VDR gene polymorphisms were selected for investigation. 187 (130 ...

Citation Formats

E. Evin, “INVESTIGATION OF EFFECTS OF VITAMIN D AND VITAMIN D METABOLIZING CYP450 ISOZYMES ON MULTIPLE SCLEROSIS PATHOPHYSIOLOGY IN ANIMAL MODEL BY MOLECULAR APPROACHES,” Ph.D. - Doctoral Program, Middle East Technical University, 2021.